Los Angeles Capital Management LLC / BMY
Los Angeles Capital Management LLC’s Bristol-Myers Squibb Co Position
Does Los Angeles Capital Management LLC own Bristol-Myers Squibb Co (BMY)? Yes — 4.26M shares worth $258M (+1.02% of its 13F portfolio) as of Q1 2026, down from 4.32M shares the prior filed quarter.
Position Value
$258M
Q1 2026
Shares
4.26M
% of Portfolio
+1.02%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.26M | $258M | +1.02% |
| Q4 2025 | 4.32M | $197M | +0.67% |
| Q3 2025 | 3.22M | $145M | +0.49% |
| Q2 2025 | 988.6K | $46M | +0.17% |
| Q1 2025 | 2.40M | $146M | +0.65% |
| Q4 2024 | 2.28M | $129M | +0.52% |
| Q3 2024 | 3.60M | $186M | +0.75% |
| Q2 2024 | 1.64M | $68M | +0.24% |
| Q1 2024 | 1.81M | $98M | +0.34% |
| Q4 2023 | 1.91M | $98M | +0.37% |
| Q3 2023 | 1.54M | $89M | +0.38% |
| Q2 2023 | 1.52M | $97M | +0.39% |
| Q1 2023 | 2.22M | $154M | +0.68% |
| Q4 2022 | 2.39M | $172M | +0.83% |
| Q3 2022 | 2.23M | $159M | +0.82% |
| Q2 2022 | 1.63M | $125M | +0.62% |
| Q1 2022 | 984.8K | $72M | +0.28% |
| Q4 2021 | 923.7K | $58M | +0.21% |
| Q3 2021 | 648.2K | $38M | +0.18% |
| Q2 2021 | 762.9K | $51M | +0.22% |
| Q1 2021 | 848.8K | $54M | +0.24% |
| Q4 2020 | 856.0K | $53M | +0.23% |
| Q3 2020 | 841.1K | $51M | +0.23% |
| Q2 2020 | 1.39M | $82M | +0.39% |
| Q1 2020 | 1.37M | $76M | +0.48% |
| Q4 2019 | 853.4K | $55M | +0.27% |
| Q3 2019 | 899.2K | $46M | +0.25% |
| Q2 2019 | 928.6K | $42M | +0.23% |
| Q1 2019 | 1.24M | $59M | +0.33% |
| Q4 2018 | 3.26M | $169M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of BMY.